Truist Financial’s Verrica Pharmaceuticals VRCA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-1,055
| Closed | -$15.3K | – | 2611 |
|
|
2024
Q3 | $15.3K | Hold |
1,055
| – | – | ﹤0.01% | 2464 |
|
|
2024
Q2 | $76.9K | Hold |
1,055
| – | – | ﹤0.01% | 2582 |
|
|
2024
Q1 | $62.4K | Hold |
1,055
| – | – | ﹤0.01% | 2564 |
|
|
2023
Q4 | $77.2K | Sell |
1,055
-538
| -34% | -$39.4K | ﹤0.01% | 2572 |
|
|
2023
Q3 | $61.9K | Hold |
1,593
| – | – | ﹤0.01% | 2534 |
|
|
2023
Q2 | $91.9K | Buy |
1,593
+463
| +41% | +$26.7K | ﹤0.01% | 2508 |
|
|
2023
Q1 | $73.4K | Hold |
1,130
| – | – | ﹤0.01% | 2508 |
|
|
2022
Q4 | $31.1K | Hold |
1,130
| – | – | ﹤0.01% | 2515 |
|
|
2022
Q3 | $33K | Hold |
1,130
| – | – | ﹤0.01% | 2468 |
|
|
2022
Q2 | $21K | Hold |
1,130
| – | – | ﹤0.01% | 2590 |
|
|
2022
Q1 | $92K | Buy |
+1,130
| New | +$92K | ﹤0.01% | 2599 |
|